What Is a Middle Cerebral Artery (MCA) Stroke?

A stroke is a sudden interruption of blood flow to the brain, leading to cell death due to lack of oxygen. The Middle Cerebral Artery (MCA) stroke is the most frequently encountered type of ischemic stroke, accounting for approximately 85% of all strokes. MCA strokes affect a large and functionally significant territory of the brain, resulting in severe deficits. The specific location of the blockage within the MCA determines the precise pattern and severity of the impairment.

The Role of the Middle Cerebral Artery

The Middle Cerebral Artery is the largest of the three main paired arteries supplying blood to the cerebrum, originating as a branch of the internal carotid artery. It runs through the lateral sulcus, sending branches to a vast portion of the outer surface of the cerebral hemisphere, including the frontal, temporal, and parietal lobes. The MCA supplies areas responsible for functions such as movement, sensation, speech, and language comprehension.

The MCA is divided into segments, with deeper branches supplying subcortical structures like the basal ganglia and the internal capsule. The internal capsule contains nearly all the motor and sensory fibers connecting the brain to the rest of the body. A blockage in the main trunk (proximal occlusion) cuts off blood flow to both deep and superficial structures, resulting in widespread neurological deficits.

The vast majority of MCA strokes are ischemic, caused by a blood clot obstructing the artery, though they can less commonly be hemorrhagic. The artery’s prominent size and direct connection to the internal carotid artery make it the most common site for stroke-causing emboli to lodge. Understanding the territory supplied by the MCA helps predict the clinical presentation of a stroke.

Recognizing the Specific Symptoms

Symptoms of an MCA stroke appear on the side of the body opposite the affected brain hemisphere. A hallmark sign is hemiparesis, or weakness/paralysis affecting one side of the body, often more pronounced in the face and arm than in the leg. This pattern occurs because the MCA supplies the motor and sensory cortices dedicated to the upper body and face.

When the dominant hemisphere (usually the left) is affected, the patient experiences aphasia, a disorder that impairs language. Damage to the frontal lobe’s Broca’s area causes expressive aphasia, where the patient struggles to form words or speak fluently. Damage to the temporal lobe’s Wernicke’s area results in receptive aphasia, where the patient has difficulty understanding language.

Another common deficit is homonymous hemianopia, a visual field defect where the patient loses the ability to see in the same half of the visual field in both eyes. If the non-dominant hemisphere (typically the right) is affected, neglect may occur, causing the patient to ignore the opposite side of their body and environment. Symptom severity is often directly related to whether the blockage is proximal (affecting the main trunk) or distal (affecting only a smaller branch).

Emergency Diagnosis and Acute Care

Stroke management operates under the principle that “time is brain,” as interrupted blood flow rapidly leads to the death of neurons. Emergency medical services are immediately activated upon suspicion of stroke, and the patient is rapidly transported to a specialized stroke center. The first step in the emergency department is determining the nature of the stroke—ischemic or hemorrhagic—which guides treatment decisions.

Initial diagnosis involves an immediate non-contrast Computed Tomography (CT) scan of the head to rule out a hemorrhage. If the CT scan is negative for bleeding, a CT angiography (CTA) or Magnetic Resonance Imaging (MRI) is often performed. These scans confirm the ischemic stroke, locate the occlusion site in the MCA, and assess the extent of brain tissue at risk. The severity of the neurological deficit is quickly quantified using the National Institutes of Health Stroke Scale (NIHSS).

Acute care for an ischemic MCA stroke focuses on reperfusion, the urgent restoration of blood flow. The first-line pharmacological treatment is intravenous thrombolysis using a clot-busting drug like tissue plasminogen activator (IV tPA). This treatment is highly time-sensitive and must be administered within a 4.5-hour window from symptom onset, provided there are no contraindications.

For patients with a large vessel occlusion (LVO) in the proximal MCA, mechanical thrombectomy is the preferred intervention. This endovascular procedure involves physically removing the clot using a specialized device, such as a stent retriever, guided through catheters. Mechanical thrombectomy has an expanded therapeutic window, often up to 6 hours or longer based on imaging, and is the gold standard for treating these large clots.